Vitamin D Receptor-Mediated Upregulation of CYP3A4 and MDR1 by Quercetin in Caco-2 cells

 

 Buy Article Permissions and Reprints

Abstract

To examine whether quercetin interacts with vitamin D receptor, we investigated the effects of quercetin on vitamin D receptor activity in human intestinal Caco-2 cells. The effects of quercetin on the expression of the vitamin D receptor target genes, vitamin D₃ 24-hydroxylase, cytochrome P450 3A4, multidrug resistance protein 1, and transient receptor potential vanilloid type 6 were measured using quantitative polymerase chain reaction. The vitamin D receptor siRNA was used to assess the involvement of the vitamin D receptor. Vitamin D receptor activation using a vitamin D responsive element-mediated cytochrome P450 3A4 reporter gene assay was investigated in Caco-2 cells transfected with human vitamin D receptor. We also studied the magnitude of the vitamin D receptor activation and/or synergism between 1α,25-dihydroxyvitamin D₃ [1,25(OH)₂D₃] and quercetin-like flavonoids. Slight but significant increases in the mRNA expression of cytochrome P450 3A4, vitamin D₃ 24-hydroxylase, multidrug resistance protein 1, and transient receptor potential vanilloid type 6 were observed after 3 days of continual quercetin treatment. The silencing effect of vitamin D receptor by vitamin D receptor siRNA in Caco-2 cells significantly attenuated the induction of the vitamin D receptor target genes. Moreover, quercetin significantly enhanced cytochrome P450 3A4 reporter activity in Caco-2 cells in a dose-dependent manner, and the expression of exogenous vitamin D receptor further stimulated the vitamin D receptor activity. Quercetin-like flavonoids such as kaempferol stimulated the vitamin D receptor activity in a manner similar to that seen with quercetin. Taken together, the data indicates that quercetin upregulates cytochrome P450 3A4 and multidrug resistance protein 1 expression in Caco-2 cells likely via a vitamin D receptor-dependent pathway.

^* These authors contributed equally to this work.

• References

• 1 DeLuca HF, Zierold C. Mechanisms and functions of vitamin D. Nutr Rev 1998; 56: S4-S10
  PubMedGoogle Scholar
• 2 Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, Haussler MR, Mangelsdorf DJ. Vitamin D receptor as an intestinal bile acid sensor. Science 2002; 17: 1313-1316
  PubMedGoogle Scholar
• 3 Salusky IB. Are new vitamin D analogues in renal bone disease superior to calcitriol?. Pediatr Nephrol 2005; 20: 393-398
  CrossrefPubMedGoogle Scholar
• 4 Zierold C, Mings JA, Deluca HF. 19nor-1,25-dihydroxyvitamin D₂ specifically induces CYP3A9 in rat intestine more strongly than 1, 25-dihydroxyvitamin D₃ in vivo and in vitro . Mol Pharmacol 2006; 69: 1740-1747
  CrossrefPubMedGoogle Scholar
• 5 Haussler MR, Jurutka PW, Mizwicki M, Norman AW. Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab 2011; 25: 543-559
  CrossrefPubMedGoogle Scholar
• 6 Thummel KE, Brimer C, Yasuda K, Thottassery J, Senn T, Lin Y, Ishizuka H, Kharasch E, Schuetz J, Schuetz E. Transcriptional control of intestinal cytochrome P-4503A by 1α,25-dihydroxy vitamin D₃ . Mol Pharmacol 2001; 60: 1399-1406
  PubMedGoogle Scholar
• 7 Chen X, Chen F, Liu S, Glaeser H, Dawson PA, Hofmann AF, Kim RB, Shneider BL, Pang KS. Transactivation of rat apical sodium-dependent bile acid transporter and increased bile acid transport by 1α,25-dihydroxyvitamin D₃ via the vitamin D receptor. Mol Pharmacol 2006; 69: 1913-1923
  CrossrefPubMedGoogle Scholar
• 8 Chow EC, Maeng HJ, Liu S, Khan AA, Groothuis GM, Pang KS. 1α,25-Dihydroxyvitamin D₃ triggered vitamin D receptor and farnesoid X receptor-like effects in rat intestine and liver in vivo . Biopharm Drug Dispos 2009; 30: 457-475
  CrossrefPubMedGoogle Scholar
• 9 Fan J, Liu S, Du Y, Morrison J, Shipman R, Pang KS. Upregulation of transporters and enzymes by the vitamin D receptor ligands, 1α,25-dihydroxyvitamin D₃ and vitamin D analogs, in the Caco-2 cell monolayer. J Pharmacol Exp Ther 2009; 330: 389-402
  CrossrefPubMedGoogle Scholar
• 10 Chow EC, Sun H, Khan AA, Groothuis GM, Pang KS. Effects of 1α,25-dihydroxyvitamin D₃ on transporters and enzymes of the rat intestine and kidney in vivo . Biopharm Drug Dispos 2010; 31: 91-108
  PubMedGoogle Scholar
• 11 Maeng HJ, Durk MR, Chow EC, Ghoneim R, Pang KS. 1α,25-Dihydroxyvitamin D₃ on intestinal transporter function: studies with the rat everted intestinal sac. Biopharm Drug Dispos 2011; 32: 112-125
  CrossrefPubMedGoogle Scholar
• 12 Maeng HJ, Chapy H, Zaman S, Pang KS. Effects of 1α,25-dihydroxyvitamin D3 on transport and metabolism of adefovir dipivoxil and its metabolites in Caco-2 cells. Eur J Pharm Sci 2012; 46: 149-166
  CrossrefPubMedGoogle Scholar
• 13 Khan AA, Chow EC, van Loenen-Weemaes AM, Porte RJ, Pang KS, Groothuis GM. Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver. Eur J Pharm Sci 2009; 12: 115-125
  PubMedGoogle Scholar
• 14 Tachibana S, Yoshinari K, Chikada T, Toriyabe T, Nagata K, Yamazoe Y. Involvement of Vitamin D receptor in the intestinal induction of human ABCB1. Drug Metab Dispos 2009; 37: 1604-1610
  CrossrefPubMedGoogle Scholar
• 15 Xu Y, Iwanaga K, Zhou C, Cheesman MJ, Farin F, Thummel KE. Selective induction of intestinal CYP3A23 by 1α,25-dihydroxyvitamin D₃ in rats. Biochem Pharmacol 2006; 28: 385-392
  PubMedGoogle Scholar
• 16 Choi M, Makishima M. Therapeutic applications for novel non-hypercalcemic vitamin D receptor ligands. Expert Opin Ther Pat 2009; 19: 593-606
  CrossrefPubMedGoogle Scholar
• 17 Ma Y, Khalifa B, Yee YK, Lu J, Memezawa A, Savkur RS, Yamamoto Y, Chintalacharuvu SR, Yamaoka K, Stayrook KR, Bramlett KS, Zeng QQ, Chandrasekhar S, Yu XP, Linebarger JH, Iturria SJ, Burris TP, Kato S, Chin WW, Nagpal S. Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators. J Clin Invest 2006; 116: 892-904
  CrossrefPubMedGoogle Scholar
• 18 Inaba Y, Yamamoto K, Yoshimoto N, Matsunawa M, Uno S, Yamada S, Makishima M. Vitamin D3 derivatives with adamantane or lactone ring side chains are cell type-selective vitamin D receptor modulators. Mol Pharmacol 2007; 71: 1298-1311
  CrossrefPubMedGoogle Scholar
• 19 Russo M, Spagnuolo C, Tedesco I, Bilotto S, Russo GL. The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem Pharmacol 2012; 83: 6-15
  CrossrefPubMedGoogle Scholar
• 20 Inoue J, Choi JM, Yoshidomi T, Yashiro T, Sato R. Quercetin enhances VDR activity, leading to stimulation of its target gene expression in Caco-2 cells. J Nutr Sci Vitaminol (Tokyo) 2010; 56: 326-330
  CrossrefPubMedGoogle Scholar
• 21 Harmsen S, Koster AS, Beijnen JH, Schellens JH, Meijerman I. Comparison of two immortalized human cell lines to study nuclear receptor-mediated CYP3A4 induction. Drug Metab Dispos 2008; 36: 1166-1171
  CrossrefPubMedGoogle Scholar
• 22 Wacher VJ, Wu CY, Benet LZ. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol Carcinog 1995; 13: 129-134
  CrossrefPubMedGoogle Scholar
• 23 Schuetz EG, Beck WT, Schuetz JD. Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately upregulate these proteins in human colon carcinoma cells. Mol Pharmacol 1996; 49: 311-318
  PubMedGoogle Scholar
• 24 Urquhart B, Tirona R, Kim R. Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs. J Clin Pharmacol 2007; 47: 566-578
  CrossrefPubMedGoogle Scholar
• 25 Fan J, Maeng HJ, Du Y, Kwan D, Pang KS. Transport of 5, 5-diphenylbarbituric acid and its precursors and their effect on P-gp, MRP2 and CYP3A4 in Caco-2 and LS180 cells. Eur J Pharm Sci 2011; 42: 19-29
  CrossrefPubMedGoogle Scholar
• 26 Ishizawa M, Matsunawa M, Adachi R, Uno S, Ikeda K, Masuno H, Shimizu M, Iwasaki K, Yamada S, Makishima M. Lithocholic acid derivatives act as selective vitamin D receptor modulators without inducing hypercalcemia. J Lipid Res 2008; 49: 763-772
  CrossrefPubMedGoogle Scholar
• 27 Patel J, Buddha B, Dey S, Pal D, Mitra AK. In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity. Am J Ther 2004; 11: 262-277
  CrossrefPubMedGoogle Scholar
• 28 Chieli E, Romiti N, Cervelli F, Tongiani R. Effects of flavonols on P-glycoprotein activity in cultured rat hepatocytes. Life Sci 1995; 57: 1741-1751
  CrossrefPubMedGoogle Scholar
• 29 Scambia G, Ranelletti FO, Panici PB, De Vincenzo R, Bonanno G, Ferrandina G, Piantelli M, Bussa S, Rumi C, Cianfriglia M, Mancuso S. Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemother Pharmacol 1994; 34: 459-464
  CrossrefPubMedGoogle Scholar
• 30 Rastogi H, Jana S. Evaluation of inhibitory effects of caffeic acid and quercetin on human liver cytochrome p 450 activities. Phytother Res 2014; 28: 1873-1878
  CrossrefPubMedGoogle Scholar
• 31 Pal D, Mitra AK. MDR- and CYP3A4-mediated drug-herbal interactions. Life Sci 2006; 78: 2131-2145
  CrossrefPubMedGoogle Scholar
• 32 Raucy JL. Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products. Drug Metab Dispos 2003; 31: 533-539
  CrossrefPubMedGoogle Scholar
• 33 Kluth D, Banning A, Paur I, Blomhoff R, Brigelius-Flohé R. Modulation of pregnane X receptor- and electrophile responsive element-mediated gene expression by dietary polyphenolic compounds. Free Radic Biol Med 2007; 42: 315-325
  CrossrefPubMedGoogle Scholar
• 34 Waizenegger J, Lenze D, Luckert C, Seidel A, Lampen A, Hassel S. Dose-dependent induction of signaling pathways by the flavonoid quercetin in human primary hepatocytes: A transcriptomic study. Mol Nutr Food Res 2015; 59: 1117-1129
  CrossrefPubMedGoogle Scholar
• 35 Taipalensuu J, Törnblom H, Lindberg G, Einarsson C, Sjöqvist F, Melhus H, Garberg P, Sjöström B, Lundgren B, Artursson P. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J Pharmacol Exp Ther 2001; 299: 164-170
  PubMedGoogle Scholar
• 36 Lai CY, Yang JY, Rayalam S, Della-Fera MA, Ambati S, Lewis RD, Hamrick MW, Hartzell DL, Baile CA. Preventing bone loss and weight gain with combinations of vitamin D and phytochemicals. J Med Food 2011; 14: 1352-1362
  CrossrefPubMedGoogle Scholar
• 37 Bartik L, Whitfield GK, Kaczmarska M, Lowmiller CL, Moffet EW, Furmick JK, Hernandez Z, Haussler CA, Haussler MR, Jurutka PW. Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention. J Nutr Biochem 2010; 21: 1153-1161
  CrossrefPubMedGoogle Scholar
• 38 Wang K, Chen S, Xie W, Wan YJ. Retinoids induce cytochrome P450 3A4 through RXR/VDR-mediated pathway. Biochem Pharmacol 2008; 75: 2204-2213
  CrossrefPubMedGoogle Scholar
• 39 Maeng HJ, Yoo HJ, Kim IW, Song IS, Chung SJ, Shim CK. P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers. J Pharm Sci 2002; 91: 2614-2621
  CrossrefPubMedGoogle Scholar
• 40 Thompson PD, Jurutka PW, Whitfield GK, Myskowski SM, Eichhorst KR, Domingue CE, Haussler CA, Haussler MR. Liganded VDR induces CYP3A4 in small intestinal and colon cancer cells via DR3 and ER6 vitamin D responsive elements. Biochem Biophys Res Commun 2002; 299: 730-738
  CrossrefPubMedGoogle Scholar

• Supplementary Material